Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Bone Marrow Transplantation
|
September 12, 2001
Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation
M H Wu, S L Smith, G H Danet, et al.
Cancer Research
|
September 1, 1994
Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts
M E Dolan, M J Fleig, B G Feuerstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients
A B Benson, O I Olopade, M J Ratain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer
R L Schilsky, M E Dolan, D Bertucci, et al.
Biochemical Pharmacology
|
June 20, 1998
O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases
M E Dolan, S K Roy, B J Garbiras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1995
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent
E Gupta, O I Olopade, M J Ratain, et al.
Cancer Research
|
July 1, 1995
Activity of temozolomide in the treatment of central nervous system tumor xenografts
H S Friedman, M E Dolan, A E Pegg, et al.
Anti-Cancer Drugs
|
July 11, 1998
Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents
M E Dolan, B Frydman, C B Thompson, et al.
Journal of the National Cancer Institute
|
December 26, 1992
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme
H S Friedman, M E Dolan, R C Moschel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer
R A Humerickhouse, M E Dolan, D J Haraf, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Bone Marrow Transplantation
|
September 12, 2001
Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation
M H Wu, S L Smith, G H Danet, et al.
Cancer Research
|
September 1, 1994
Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts
M E Dolan, M J Fleig, B G Feuerstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients
A B Benson, O I Olopade, M J Ratain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer
R L Schilsky, M E Dolan, D Bertucci, et al.
Biochemical Pharmacology
|
June 20, 1998
O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases
M E Dolan, S K Roy, B J Garbiras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1995
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent
E Gupta, O I Olopade, M J Ratain, et al.
Cancer Research
|
July 1, 1995
Activity of temozolomide in the treatment of central nervous system tumor xenografts
H S Friedman, M E Dolan, A E Pegg, et al.
Anti-Cancer Drugs
|
July 11, 1998
Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents
M E Dolan, B Frydman, C B Thompson, et al.
Journal of the National Cancer Institute
|
December 26, 1992
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme
H S Friedman, M E Dolan, R C Moschel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 1999
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer
R A Humerickhouse, M E Dolan, D J Haraf, et al.
Page
of 12